Ohio Revised Code Search

...ase of a prescription that authorizes a drug to be dispensed by refilling the prescription one or more times and the total quantity or amount of the drug that may be dispensed by filling and refilling the prescription does not exceed a ninety-day supply of the drug, a pharmacist who is filling or refilling the prescription may dispense a quantity or amount of the drug that varies from the quantity or amount of the dr...

... on a terminal distributor of dangerous drugs for any of the causes set forth in division (B) of this section: (1) Suspend, revoke, restrict, limit, or refuse to grant or renew any license; (2) Reprimand or place the license holder on probation; (3) Impose a monetary penalty or forfeiture not to exceed in severity any fine designated under the Revised Code for a similar offense or one thousand dollars if the ac...

...t is consumed or used by humans and any drug, including a drug that may be provided legally only pursuant to a prescription, that is intended to be consumed or used by humans. (2) "Terminal distributor of dangerous drugs" has the same meaning as in section 4729.01 of the Revised Code. (3) "Pseudoephedrine" means any material, compound, mixture, or preparation that contains any quantity of pseudoephedrine, any of ...

...(A) For each alcohol, drug addiction, and mental health service district, there shall be appointed a board of alcohol, drug addiction, and mental health services. As provided in this section, the board shall consist of eighteen members, fifteen members, fourteen members, twelve members, or nine members. In a single-county district, the size of the board shall be determined by the board of county commissioners repr...

...lding or offering for sale of any food, drug, device, or cosmetic that is adulterated or misbranded; (2) The adulteration or misbranding of any food, drug, device, or cosmetic; (3) The receipt in commerce of any food, drug, device, or cosmetic that is adulterated or misbranded, and the delivery or proffered delivery thereof for pay or otherwise; (4) The sale, delivery for sale, holding for sale, or offering for sa...

...isconduct, a person who administers the drug naltrexone by injection, the person's employer, and the facility at which the drug is administered are not liable in any civil action or subject to criminal prosecution or professional discipline for any injury or damage caused by the injection or drug if all of the following conditions are met: (A) The individual to whom the drug is administered is unable to have it adm...

...ster a health care service, item, or drug for the treatment of cancer; (ii) Tests responses to a health care service, item, or drug for the treatment of cancer; (iii) Compares the effectiveness of a health care service, item, or drug for the treatment of cancer with that of other health care services, items, or drugs for the treatment of cancer; (iv) Studies new uses of a health care service, item, or ...

...of pharmacy establishes and maintains a drug database pursuant to section 4729.75 of the Revised Code, each licensed health professional authorized to prescribe drugs, except as provided in division (C) of this section, who personally furnishes to a patient a controlled substance, naltrexone, or other dangerous drug the board includes in the database pursuant to rules adopted under section 4729.84 of the Revised Code...

...poses of establishing and maintaining a drug database pursuant to section 4729.75 of the Revised Code, the state board of pharmacy shall adopt rules in accordance with Chapter 119. of the Revised Code to carry out and enforce sections 4729.75 to 4729.83 of the Revised Code. The rules shall specify all of the following: (A) A means of identifying each patient, each terminal distributor of dangerous drugs, each purcha...

...n, "eligible patient," "investigational drug, product, or device," "terminal condition," and "treating physician" have the same meanings as in section 4731.97 of the Revised Code. (B) A manufacturer of dangerous drugs may, in accordance with section 4731.97 of the Revised Code, provide an investigational drug, product, or device for treatment of a terminal condition to an eligible patient or to the treating physici...

...re or that of others; (b) The use of a drug of abuse to the extent that the user becomes physically or psychologically dependent on the drug or endangers the user's health, safety, or welfare or that of others. (3) "Drug of abuse" has the same meaning as in section 3719.011 of the Revised Code. (B) If the juvenile court issues an order of temporary custody or protective supervision under division (A) of section 21...

...hall knowingly furnish another a sample drug. (B) Division (A) of this section does not apply to manufacturers, wholesalers, pharmacists, owners of pharmacies, licensed health professionals authorized to prescribe drugs, and other persons whose conduct is in accordance with Chapters 3719., 4715., 4723., 4725., 4729., 4730., 4731., 4741., and 4772. of the Revised Code. (C)(1) Whoever violates this section is guilt...

...he Revised Code, each board of alcohol, drug addiction, and mental health services shall: (1) Serve as the community addiction and mental health planning agency for the county or counties under its jurisdiction, and in so doing it shall: (a) Evaluate the need for facility services, addiction services, mental health services, and recovery supports; (b) In cooperation with other local and regional planning and...

...stics provider, repackager of dangerous drugs, licensed health professional authorized to prescribe drugs, pharmacist, terminal distributor of dangerous drugs with a category III license issued under section 4729.54 of the Revised Code, or other person authorized to possess controlled substances under this chapter or Chapter 4729. of the Revised Code; (B) Possession by any person of any schedule V narcotic drug exe...

... Code. (B) With regard to a dangerous drug that is indicated for the treatment of cancer or a cancer-related illness, must be administered intravenously or by subcutaneous injection, and cannot reasonably be self-administered by the patient to whom the drug is prescribed or by an individual assisting the patient with the self-administration, a pharmacist shall not dispense the drug by delivering the drug directly t...

...of pharmacy establishes and maintains a drug database pursuant to section 4729.75 of the Revised Code, each pharmacy licensed as a terminal distributor of dangerous drugs that dispenses drugs to patients in this state and is included in the types of pharmacies specified in rules adopted under section 4729.84 of the Revised Code shall submit to the board the following prescription information: (1) Terminal distributo...

...e met, may delegate administration of a drug. Subject to division (D) of section 4730.03 of the Revised Code, delegation may be to any person. The physician assistant must be physically present at the location where the task is performed or the drug administered. (B) Prior to delegating a task or administration of a drug, a physician assistant shall determine that the task or drug is appropriate for the patient and ...

... this section: (1) "Abortion-inducing drug" means a drug or regimen of drugs that causes the termination of a clinically diagnosable pregnancy, including any drug identified in section 2919.123 of the Revised Code. (2) "Physician" has the same meaning as in section 2305.113 of the Revised Code. (3) "Professionally licensed person" has the same meaning as in section 2925.01 of the Revised Code. (B) No physicia...

... by a court that an offender is a major drug offender is precluded unless the indictment, count in the indictment, or information charging the offender specifies that the offender is a major drug offender. The specification shall be stated at the end of the body of the indictment, count, or information, and shall be stated in substantially the following form: "SPECIFICATION (or, SPECIFICATION TO THE FIRST COUNT). Th...

...th professional authorized to prescribe drugs" and "prescriber" have the same meanings as in section 4729.01 of the Revised Code. (B) The board of education of each city, local, exempted village, or joint vocational school district may procure injectable or nasally administered glucagon for each school operated by the district to have on the school premises for use in emergency situations identified under division...

...lated to activities conducted under the drug repository program, all of the following apply: (1) A pharmacy, drug manufacturer, health care facility, or other person or government entity that donates or gives drugs to the program, and any person or government entity that facilitates the donation or gift, shall not be subject to liability in tort or other civil action for injury, death, or loss to person or property...

...ance than is provided under the federal drug abuse control laws; (3) Remove a compound, mixture, preparation, or substance from the schedules where the board had previously added the compound, mixture, preparation, or substance to the schedules, provided that the removal shall not have the effect under this chapter of providing less stringent control of the compound, mixture, preparation, or substance than is provid...

...ho uses, possesses, or trafficks in any drug of abuse appears necessary to an investigation by law enforcement authorities into illicit sources of any drug of abuse, or appears necessary to successfully institute, maintain, or conclude a prosecution for any drug abuse offense, as defined in section 2925.01 of the Revised Code, a judge of the court of common pleas may grant to that person immunity from prosecution for...

... payment for the provision of dangerous drugs for which the payer or the auditing entity does not impose a penalty or demand to recoup money from the pharmacy in any amount. (D) "Dangerous drug," "pharmacy," "practice of pharmacy," and "prescription" have the same meanings as in section 4729.01 of the Revised Code. (E) "Payer" means any of the following that pays for or processes a claim for payment for the provisi...

...nish the following data for any and all drugs covered under a related health benefit plan: (1) The covered person's eligibility information for any and all covered drugs; (2) Cost-sharing information for any and all covered drugs, including a description of any variance in cost-sharing based on pharmacy, whether retail or mail order, or health care provider dispensing or administering the drugs; (3) Any applica...